Andrew Wood, MD

Andrew M. Wood, M.D. is a urological surgeon specializing in the surgical treatment and management of urologic cancers, including prostate, bladder, and kidney cancers. With advanced fellowship training in complex open, minimally invasive laparoscopic/robotic, and focal ablative techniques for Urologic cancers, he is able to apply the correct tool according to each patient’s unique clinical situation.
Dr. Wood’s research interests focus on the investigation and optimization of imaging-guided ablative therapies for prostate and kidney cancer. By enhancing the understanding of the interplay between advanced imaging technologies such as Prostate MRI and ablative modalities such as high-intensity focused ultrasound, cryotherapy, and irreversible electroporation, he hopes to continuously improve the oncologic and patient centered outcomes of these important cutting-edge techniques.
Dr. Wood was born and raised in Michigan and graduated from the University of Michigan before receiving his MD from Georgetown University School of Medicine. He completed his urology residency in New York City at Maimonides Medical Center. Subsequently, he completed a Society of Urologic Oncology (SUO) fellowship at the Cleveland Clinic before returning home to join the faculty at the University of Michigan.